Showing results (221-230 of 350) with videos related to
Sort By:
Pageof 35
Journal of Experimental & Clinical Cancer Research : CR|May 17, 2011
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trialsFederica Cuppone, Emilio Bria, Vanja Vaccaro, et al.Future Oncology (London, England)|December 20, 2014
BMI variation increases recurrence risk in women with early-stage breast cancerPalma Fedele, Laura Orlando, Paola Schiavone, et al.Communications Biology|October 2, 2020
BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancerFabiana Conciatori, Chiara Bazzichetto, Carla Azzurra Amoreo, et al.Cancers|June 10, 2022
External Validation of a Prognostic Score for Survival in Lung CarcinoidsMarco Chiappetta, Diomira Tabacco, Carolina Sassorossi, et al.Clinical Breast Cancer|July 19, 2014
Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with trastuzumab and docetaxelEmilio Bria, Jenny Furlanetto, Luisa Carbognin, et al.Cancer Treatment Reviews|June 1, 2014
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsEmilio Bria, Luisa Carbognin, Jenny Furlanetto, et al.Immunotherapy|June 4, 2019
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysisAntonio Rossi, Vincenzo Di Noia, Anastasios Gkountakos, et al.Breast Cancer Research and Treatment|September 21, 2014
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case seriesLuigi Di Lauro, Patrizia Vici, Maddalena Barba, et al.Neurosurgical Review|October 29, 2024
The role of surgery in recurrent local cerebral metastases: a multi-institutional retrospective analysisStefano Telera, Luigino Tosatto, Roberto Colasanti, et al.Oncotarget|January 10, 2018
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancersGiulia Bon, Rossella Loria, Carla Azzurra Amoreo, et al.Pageof 35